TY - JOUR
T1 - Primary lateral sclerosis
T2 - consensus diagnostic criteria
AU - Turner, Martin R
AU - Barohn, Richard J
AU - Corcia, Philippe
AU - Fink, John K
AU - Harms, Matthew B
AU - Kiernan, Matthew C
AU - Ravits, John
AU - Silani, Vincenzo
AU - Simmons, Zachary
AU - Statland, Jeffrey
AU - van den Berg, Leonard H
AU - Mitsumoto, Hiroshi
N1 - Funding Information:
MRT is supported by the Motor Neurone Disease Association. MCK was supported by the National Health and Medical Research Council of Australia Program Grant (#1132524), Partnership Project (1153439) and Practitioner Fellowship (1156093). VS was supported by the Italian Ministry of Health, AriSLA (Fondazione Italiana di Ricerca per la SLA), and E-R are Joint Transnational Call. ZS received funding from Cytokinetics, Biohaven & Biogen. HM received funding from CDC, MDA, SPF, Cytokinetics and Tsumura.
Funding Information:
Funding MrT is supported by the Motor neurone Disease association. McK was supported by the national health and Medical research council of australia Program grant (#1132524), Partnership Project (1153439) and Practitioner Fellowship (1156093). Vs was supported by the italian Ministry of health, arisla (Fondazione italiana di ricerca per la sla), and e-rare Joint Transnational call. Zs received funding from cytokinetics, Biohaven & Biogen. hM received funding from cDc, MDa, sPF, cytokinetics and Tsumura.
Publisher Copyright:
© 2020 Author(s).
PY - 2020/4
Y1 - 2020/4
N2 - Primary lateral sclerosis (PLS) is a neurodegenerative disorder of the adult motor system. Characterised by a slowly progressive upper motor neuron syndrome, the diagnosis is clinical, after exclusion of structural, neurodegenerative and metabolic mimics. Differentiation of PLS from upper motor neuron-predominant forms of amyotrophic lateral sclerosis remains a significant challenge in the early symptomatic phase of both disorders, with ongoing debate as to whether they form a clinical and histopathological continuum. Current diagnostic criteria for PLS may be a barrier to therapeutic development, requiring long delays between symptom onset and formal diagnosis. While new technologies sensitive to both upper and lower motor neuron involvement may ultimately resolve controversies in the diagnosis of PLS, we present updated consensus diagnostic criteria with the aim of reducing diagnostic delay, optimising therapeutic trial design and catalysing the development of disease-modifying therapy.
AB - Primary lateral sclerosis (PLS) is a neurodegenerative disorder of the adult motor system. Characterised by a slowly progressive upper motor neuron syndrome, the diagnosis is clinical, after exclusion of structural, neurodegenerative and metabolic mimics. Differentiation of PLS from upper motor neuron-predominant forms of amyotrophic lateral sclerosis remains a significant challenge in the early symptomatic phase of both disorders, with ongoing debate as to whether they form a clinical and histopathological continuum. Current diagnostic criteria for PLS may be a barrier to therapeutic development, requiring long delays between symptom onset and formal diagnosis. While new technologies sensitive to both upper and lower motor neuron involvement may ultimately resolve controversies in the diagnosis of PLS, we present updated consensus diagnostic criteria with the aim of reducing diagnostic delay, optimising therapeutic trial design and catalysing the development of disease-modifying therapy.
KW - Amyotrophic Lateral Sclerosis/diagnosis
KW - Consensus
KW - Delayed Diagnosis
KW - Diagnosis, Differential
KW - Humans
KW - Motor Neuron Disease/diagnosis
KW - Motor Neurons/pathology
UR - http://www.scopus.com/inward/record.url?scp=85079217298&partnerID=8YFLogxK
U2 - 10.1136/jnnp-2019-322541
DO - 10.1136/jnnp-2019-322541
M3 - Article
C2 - 32029539
SN - 0022-3050
VL - 91
SP - 373
EP - 377
JO - Journal of neurology, neurosurgery, and psychiatry
JF - Journal of neurology, neurosurgery, and psychiatry
IS - 4
ER -